Introduction {#s1}
============

The integrated activity across frontal cortex and other cortical and sub-cortical brain regions supports a number of cognitive processes subsumed under the term "executive function." These cognitive processes comprise: selective allocation of attentional resources, maintenance, retrieval, and manipulation of information in working memory, formulation and planning of appropriate sequences of actions, inhibition of inappropriate responses and decision-making on the basis of positive or negative outcomes. Neuropsychological evidence has suggested that executive functioning is critically dependent on the frontal cortex (Fuster, [@B104]) and indeed the term executive function and frontal lobe function have often been used interchangeably. However, numerous studies in healthy human subjects, monkeys, and rats are suggesting that executive processes are not an exclusive property of frontal cortex but that are mediated by networks incorporating multiple cortical regions (posterior/parietal and prefrontal) as well as cortico-striatal-thalamic circuitry linking regions of the frontal cortex via basal ganglia to the thalamus. The executive dysfunctions associated with basal ganglia disorders have provided further evidence that fronto-striatal circuitry rather than discrete frontal regions may be important in mediating these functions.

The neural activity in the cortico-striatal circuitry is modulated by a diversity of neurochemical influences, each contributing to its functional integrity in a specific manner. Glutamate serves as the major excitatory neurotransmitter in the brain. Given the multiplicity of its receptor subtypes, a particular neuron\'s response to glutamate is determined by the presence and organization of diverse receptor subtypes; ionotropic N-methyl D-aspartate (NMDA), AMPA and kainate and metabotropic mGlu receptors. The NMDA receptors are especially interesting as various studies show that they are able to support persistent firing of cortical neurons (Compte et al., [@B74]; Wang, [@B238]). Evidence drawn from studies with rodents, monkeys and humans using multidisciplinary approaches have suggested that neuronal signaling via glutamatergic NMDA receptors play a central role in prefrontal cortex (PFC) activity and its cognitive functions such as working memory, attention, reversal learning (Malhotra et al., [@B157]; Moghaddam and Adams, [@B171]; Honey et al., [@B130], [@B131]; Amitai and Markou, [@B14]; Neill et al., [@B180]; Arnsten et al., [@B20]; Pehrson et al., [@B189]; Wang et al., [@B237]).

The cortico-striatal circuitry receives innervations from all of the major ascending neurotransmitter systems, which include dopamine (DA), noradrenaline (NE), serotonin (5-HT), and acetycholine (ACh). Notably, studies manipulating the activity of the ascending neurotransmitter systems have demonstrated a rather selective role of these neuromodulatory systems in executive functions (Robbins, [@B210]). DA appears to play a role in stabilization of representations in processes such as working memory and attention control while NE contribute by enhancing the signal in cognitive operation of the PFC. The 5-HT has been shown to contribute in some of the processes implicated in the cognitive flexibility and impulsivity. The ACh innervation of the PFC has been implicated in attention and spatial working memory. Among these neuromodulatory pathways DA and 5-HT have received special attention for their putative involvement in the pathophysiology of neuropsychiatric disorders such as for example schizophrenia where cognitive functioning is an important indicator of outcome (Green et al., [@B114]; Lewis, [@B149]; Gold et al., [@B109]; Luck and Gold, [@B155]).

The overlap and convergence of DAergic and 5-HTergic forebrain projections with glutamatergic projections provide a framework for a complex neuronal interaction, which could support various cognitive functions. Underlying the complexity of DA- and 5-HT-glutamate interaction is the co-localization of DA and 5-HT receptors with glutamate receptors within cortico-striatal circuitry. Thus, it is apparent that specific components of executive functions may be the results of convergence points between NMDA receptor signaling and the activity in these neuromodulatory systems. The two classes the DA receptors D~1~-like (D~1~ and D~5~) and D~2~-like (D~2~, D~3~ and D~4~) all belong to G-protein coupled receptors (GPCR); the D~1~-like receptors couple to the stimulatory Gs protein while D~2~-like couple to the inhibitory Gi/Go protein. So far seven families of serotonin receptors have been identified each with numerous subtypes. With the exception of 5-HT~3~ receptor, a ligand-gated ion channel the remaining receptors belong to the superfamily of GPCR. The electrophysiological, biochemical and behavioral characteristics of the interaction DA/NMDA and 5-HT/NMDA receptors have been studied and have been reviewed extensively (Aghajanian and Marek, [@B7]; David et al., [@B82]; Castner and Williams, [@B60]; Tritsch and Sabatini, [@B234]; Celada et al., [@B62]; de Bartolomeis et al., [@B83]).

Here we will first discuss the role of prefrontocortical NMDA receptors in attention and executive control and in cortico-striatal activity. Next, we will review a series of our systematic studies comparing the performance of animals after pharmacological manipulation of DA and 5-HT receptors activity locally in the medial PFC (mPFC) or in the dorsomedial striatum (dm-STR) in animals in which glutamatergic activity was perturbed by blockade of NMDA receptor in the PFC in a task that entails selective attention and tight organization of a complex response sequence for optimal performance (Carli et al., [@B57]; Robbins, [@B208]) and which engages fronto-striatal-thalamic circuitry (Christakou et al., [@B64]; Chudasama and Muir, [@B66]; Rogers et al., [@B212]; Chudasama et al., [@B65]). Finally, we will illustrate our findings that suggest an association between NMDA receptor antagonist induced increase in glutamate release and attention deficit.

NMDA receptors in the PFC, attention, executive control, and cortico-striatal activation
========================================================================================

Attention allows the subject to engage with its environment by selecting information relevant for its behavior. The relevant information is selected by top-down modulation of neural activity in posterior cortical areas by signals arising from the PFC (Buschman and Miller, [@B45]; Saalmann et al., [@B214]; Noudoost et al., [@B182]). Various lines of evidence demonstrate that persistent firing of pyramidal cells not only support working memory (Funahashi et al., [@B103]; Wang et al., [@B237]) but it contribute also to the process of attentional selection (Lebedev et al., [@B145]). Activation of NMDA receptors on local recurrent synapses rather than AMPA receptor stimulation has been shown to support persistent neuronal activity within the mPFC during the delay period in a working memory task (Wang et al., [@B237]) but their contribution to attention-induced firing is unclear. However, the attention-driven improvements in signal stability and noise correlation in the macaque visual cortex (area V1) has been shown to depend on high NMDA/AMPA receptor ratio (Herrero et al., [@B124]).

In our studies in rats we have focused on the control of attention, specifically on the process of input selection; the selection of task-relevant inputs for further processing (Luck and Gold, [@B155]; Lustig et al., [@B156]). This aspect of attention is somewhat distinguished from that where the attention is put on the selective activation and maintenance of task-appropriate rules (Luck and Gold, [@B155]; Gilmour et al., [@B106]). The most common experimental paradigms used for examining input selection processes of attention are continuous performance tasks among, which is the 5-choice serial reaction time (5-CSRT) task (Lustig et al., [@B156]). As in most cognitive task the successful performance requires the contribution of several factors other than control of attention and may thus tap as well on executive control processes.

5-choice serial reaction time task
----------------------------------

For rats (Carli et al., [@B57]) (Figure [1](#F1){ref-type="fig"}) the requirement during the 5-CSRT task performance is to sustain spatial attention divided among five locations to detect a brief visual stimulus over a large number of trials. Performance is characterized in terms of accuracy of visual discrimination, omissions, speed of responding and by different aspects of executive control such as premature and perseverative responses (see Robbins, [@B208] for a detailed description and discussion of these performance measures). The main measure of the selective spatial attention in the 5-CSRT task is accuracy of visual discrimination. Correct responses are rewarded by a food pellet while incorrect responses or failure to respond within the allotted time (omission) result in few seconds of darkness (time out period). Accuracy is independent of omissions and it is relatively impervious to potential confounds such as changes in motor activity or motivation (see Robbins, [@B208]). Premature responses that occur before the onset of visual stimulus may arise as a consequence of animal not being able to wait for a reward related cue. These "impulsive" responses measure an aspect of response inhibition that is related to response selection but also to action restraint during waiting and could be considered a type of motor impulsivity (Evenden, [@B96]; Dalley et al., [@B78]). Nose poke responses after the correct target detection has been performed are defined as perseverative responses and are considered an indicator of "compulsivity." Perseverative responses constitute persistence in an initially rewarded behavior such as nose poke (even though is no longer rewarded) and may be regarded as inability to alter behavior in reaction to changing task demands thus representing a measure of behavioral flexibility. Premature and perseverative response result in time out. Responses during time out are not reported usually even if they may constitute an additional parameter reflecting compulsivity (Amitai and Markou, [@B14]). Finally, a measure of response latency (i.e., mean latency to make a correct response) likely reflects decision time as long as changes in motivation and motor status are ruled out.

![**Schematic diagram of the 5-choice serial reaction time task**. After a waiting period of 5 s (ITI) a target stimulus is presented for 0.5 s in one of the five apertures in a random order. The rat is allowed to make its choice to respond correctly or incorrectly. After a correct nose-poke in one of the apertures rat is rewarded with a food pellet. An incorrect nose-poke or a failure to respond within the 5 s of stimulus onset (limited hold) is followed by 5 s of darkness (time-out) and no food. Responses made during the ITI and those made after a correct or incorrect response are followed by time-out.](fncir-08-00058-g0001){#F1}

NMDA receptors in the mPFC and 5-CSRT task performance
======================================================

The NMDA glutamate receptor is a ligand-gated ion channel composed of multiple subunits, which responds rapidly to glutamate by conducting cation currents that depolarize neurons rapidly. In the cerebral cortex NMDA receptors are preferentially expressed by pyramidal neurons particularly in layers II, III, V, and VI but also in excitatory and inhibitory axon terminals (Conti et al., [@B75]) particularly on parvalbumine (PV+) labeled GABA interneurons (Huntley et al., [@B132]). Changes in cortical NMDA transmission have consequences for other neurotransmitters locally (for example GABA) and distally (for example DA and 5-HT).

The selective blockade of NMDA receptors located in the mPFC by a competitive NMDA receptor antagonist 3-(R)-2-carboxypiperazin-4-propyl-1-phosphonic acid (R-CPP) has a profound impact on rats\' performance in the 5-CSRT task (Table [1](#T1){ref-type="table"}). The performance impairment is characterized by deficit in accuracy, increased omissions and correct response latency and by a concomitant loss of executive control in the form of increased premature and perseverative responses. These effects are robust (about 20% decrease in accuracy, while the number of premature and perseverative responses are increased by 2 to 3-fold) and consistent across many independent experiments. This pattern of effects resembles to that after lesions of the mPFC (Muir et al., [@B176]; Passetti et al., [@B185]) and clearly implicates NMDA receptor signaling in the mPFC for the successful performance of the task.

###### 

**Effects of blockade of frontocortical NMDA receptors on attentional performance**.

                    **mPFC[^a^](#TN1){ref-type="table-fn"}**   **PrL PFC[^b^](#TN2){ref-type="table-fn"}**   **InF PFC[^b^](#TN2){ref-type="table-fn"}**   **ACC[^c^](#TN3){ref-type="table-fn"}**
  ----------------- ------------------------------------------ --------------------------------------------- --------------------------------------------- -----------------------------------------
  Accuracy          ↓                                          ↓                                             ↓                                             0
  Omissions         ↑                                          ↑                                             ↑                                             ↑
  Premature         ↑                                          0                                             ↑                                             0
  Perseverative     ↑                                          0                                             0                                             nr
  Latency correct   ↑                                          ↑                                             ↑                                             nr
  Latency reward    0                                          ↑                                             ↑                                             nr

Data from:

*Mirjana et al., [@B167]*,

*Murphy et al., [@B178]*,

*Pehrson et al., [@B189]*.

*mPFC, medial prefrontal cortex; PrL PFC, prelimbic prefrontal cortex; InF PFC, infralimbic prefrontal cortex; ACC, anterior cingulate cortex*.

↓, *decrease;* ↑, *increase;* 0, *no effect; nr, not reported*

The effects of systemic administration of non-competitive NMDA receptor antagonists such as phencyclidine (PCP), dizocilpine and ketamine on rats\' performance in the 5-CSRT task appears to be highly dependent on the type of treatment regimen used. First exposure to these drugs often leads to non-specific effects in some animals such as ataxia and head weaving which are incompatible with the performance of this task while after repeated exposures these effects subside and rats start to show the characteristic deficit in performance; decreased accuracy and increased impulsivity and compulsivity (Grottick and Higgins, [@B116]; Higgins et al., [@B126]; Le Pen et al., [@B148]; Amitai et al., [@B15]; Auclair et al., [@B24]; Amitai and Markou, [@B14]; Smith et al., [@B226]). In contrast rats tested after a wash-out period from sub-chronic PCP treatment do not show any performance deficit in the 5-CSRT task. However, Barnes et al. ([@B30]) using a 5-choice continuous performance task (5C-CPT), which is a version of the 5CSRT task specifically designed to add non-targets to which the subject must inhibit responding, were able to show an attention/vigilance deficit but only when the attentional load was increased.

Attentional impairment may almost certainly account for accuracy deficits observed in this task after injections of R-CPP (10--50 ng/side). However, the accuracy of rats in this task depends also on temporal organization of behavior, as responses initiated late are more likely to be incorrect. Naïve rats make the majority of nose poke responses in the holes (about 80% almost all correct) in a narrow time window (0--0.8 s) of stimulus presentation (Passetti et al., [@B185]). In analogy to what reported for mPFC lesioned rats it could not be excluded that the temporal distribution of responses of R-CPP-injected rats was more random across a much larger time window thus suggesting that they are "distracted/disorganized" (Passetti et al., [@B185]). A commission error in the 5-CSRT task may be the result of a faulty decision process, distraction or inability to hold "on-line" the planned response. Thus, it could not be excluded that additional deficit in response selection, increased distractability/disorganization and working memory may account for accuracy deficit after R-CPP. The impaired response selection is an important component of attentional deficit and the correct response latency may reflect the speed of processing involved in the input selection mechanisms of attention and in operations of decisional processes in response selection or both. Since correct and incorrect responses in this task have the same motor requirements the slowing of correct but not incorrect responses after R-CPP rule out motor impairment and could suggest the slowing of input selection processing speed. However, dysfunctional mechanisms of stimulus detection most likely due to distraction or temporal disorganization may certainly contribute. Thus, it could be argued that on occasions when the animals were able to overcome "distraction" and respond correctly they were doing it at the cost of slower responding. This indicates that animals injected with R-CPP when they correctly detected the visual stimulus could hold "on-line" mental representation of planned responses well after the visual stimulus has disappeared. In line with this suggestion are observations that control animals will compensate for the decreased salience of the visual stimulus by increasing the correct response latencies (Carli, [@B50]). That deficits in working memory may not completely account for accuracy impairments may also be suggested by recent findings of Chudasama et al. ([@B67]) who using an attention-working memory combined task have shown that rats with PFC lesions were impaired on the attentional but not on the working memory component of the task.

In addition to accuracy deficit R-CPP-injected rats made more omissions. This may suggest that rats did not orient their attention on the stimulus presentation array in time or were engaging in some other behavior thus missing the stimulus presentation. The accuracy and omission deficit were completely abolished by prolonging the stimulus duration (see Figure 3 in Mirjana et al., [@B167]). Because the frequency of stimulus presentation was regular relative to each trial initiation, when the stimulus duration was increased, the position of the visual target in both space and time was emphasized, thus facilitating accurate responding. The mean latency to collect the earned reward, which represents an additional measure of motivation and/or motor function, was not affected by R-CPP. Together, these findings rule out the possibility that the R-CPP-induced impairments in accuracy and omissions were a consequence of hyperactivity, poor motivation or a failure to make associations or remember the general rules of the task.

Impulsivity and perseveration are both intimately related to executive attentional processes that enable accurate response selection in the face of distraction and interference (Shallice, [@B224]; Robbins, [@B207]). Increasing the duration of the target stimulus reduces while decreasing it increases premature and perseverative responses suggesting that premature and perseverative responses in the 5-CSRT task may be under attentional control (Christakou et al., [@B64]; Carli, [@B50]). However, the R-CPP-induced increase in anticipatory and perseverative responses persisted even when the longer stimulus helped alleviate the accuracy and omissions deficits (see Figure 3 in Mirjana et al., [@B167]). It may be argued that there was a primary deficit of response inhibition making the animals "impulsive" and "compulsive." Increased impulsivity in this task has been reported after highly arousing stimuli such as brief presentation of loud white noise during the waiting period (Carli et al., [@B57]), which may lead to attentional deficit (Carli et al., [@B57]). The inverted U-shaped function linking arousal and performance (Yerkes and Dodson, [@B245]) has been shown in human subjects performing a 5-CSRT task under conditions of elevated arousal (Wilkinson, [@B241]). The hypo-function of NMDA receptors in the mPFC may thus lead to a behavioral profile compatible with a state of hyper-arousal. A possible contribution of NMDA antagonist-induced NE release (Lena et al., [@B147]) to the state of hyper-arousal and consequent impairment in attention cannot be excluded as high levels of tonic NE activity is associated with an inability to focus attention (Aston-Jones et al., [@B23]).

The increased perseverative responding, which is in line with that reported after excitotoxic lesions of the mPFC (Muir et al., [@B176]) could be the result of R-CPP preventing the suppression of responses once effective for obtaining reward. The perseverative deficit was not general; it was specifically directed to the stimulus array holes and not the panel of the food magazine.

Evidence for functional heterogeneity of rat PFC and NMDA receptors therein were shown by Passetti et al. ([@B185]) and Chudasama et al. ([@B68]) who reported that impairments in attentional accuracy after lesions to the mPFC (Muir et al., [@B176]; Passetti et al., [@B185]) are mainly reproduced by lesions confined to more dorsal (Cg1) aspects of PFC sparing prelimbic (PrL) and infralimbic (InF) sub-regions. However, attentional deficit induced by R-CPP injections confined to PrL or InF was less well localized (Murphy et al., [@B178]). A recent study comparing systemic and local application of dizocilpine an NMDA antagonist into the anterior cingulate cortex (ACC) (area Cg1) in rats performing a 3-choice version of the task report that while systemic administration of dizocilpine affected accuracy and omissions local application increased omissions without concomitant changes in accuracy. This finding would suggest separable roles for NMDA receptor in the PFC and ACC for the control of attention (Pehrson et al., [@B189]). The PrL sub-region of PFC has been shown to be particularly involved in perseverative responding (Passetti et al., [@B185]; Chudasama et al., [@B68]) whereas lesions or blockade of NMDA receptors in the InF sub-region mainly affect premature "impulsive" responding (Chudasama et al., [@B68]; Murphy et al., [@B178]). However, in the study by Murphy et al. ([@B178]) perseverative responses were not affected by blockade of NMDA receptors in the PrL. The failure to see changes in this behavior may reflect the fact that in contrast to studies in which perseverative errors are followed by darkness and time-out (Passetti et al., [@B185]; Chudasama et al., [@B68]; Mirjana et al., [@B167]) in the study by Murphy et al. ([@B178]) they had no consequences. This may suggest that NMDA receptors are implicated in the control of those behaviors that are relevant for the success and not those of no-consequences.

NMDA receptors in the mPFC and cortico-striatal activation
----------------------------------------------------------

Numerous studies in rodents show that acute or repeated administration of NMDA antagonists such as PCP, dizocilpine and ketamine consistently lead to disinhibition of the firing of pyramidal neurons (Jackson et al., [@B135]) most probably by decreasing the activity of GABA interneurons (Homayoun and Moghaddam, [@B128]) whose response depends on the firing pattern of pyramidal cells (Thomson, [@B232]; Shi and Zhang, [@B225]). NMDA receptor antagonists increase glutamate, 5-HT and NE release in the PFC (Moghaddam et al., [@B170]; Moghaddam and Adams, [@B171]; Abekawa et al., [@B2]; Lena et al., [@B147]; Lopez-Gil et al., [@B153]). Systemic PCP and dizocilpine also reduce extracellular GABA in the mPFC (Yonezawa et al., [@B246]) and there is evidence that glutamate release is inhibited by GABA (Pende et al., [@B190]; Bonanno et al., [@B40]; Perkinton and Sihra, [@B191]). Similarly, intra-mPFC infusion of R-CPP to conscious rats increased glutamate efflux within this brain area (Ceglia et al., [@B61]; Abekawa et al., [@B2]; Calcagno et al., [@B49], [@B48]) and lowered GABA levels (Calcagno et al., [@B48]; Agnoli et al., [@B11]). The glutamate increase elicited by R-CPP is suppressed by TTX added to the medium perfusing the microdialysis probe suggesting that neuronal activity is required. Thus, the effect of R-CPP on extracellular glutamate may be mediated by direct or indirect suppression of cortical GABAergic transmission, which in turn enhances the release of glutamate. Employing dual-probe microdialysis technique we confirmed and extended these finding showing that R-CPP infused in the mPFC raised also extracellular levels of cortical DA whereas in the dm-STR extracellular levels of GABA were increased together with those of glutamate and DA (Agnoli et al., [@B11]). These data are summarized in Table [2](#T2){ref-type="table"}.

###### 

**Effects of R-CPP infused in the mPFC on glutamate (GLU), GABA and dopamine (DA) release in the PFC and dm-STR**.

           **GLU**   **GABA**   **DA**
  -------- --------- ---------- --------
  PFC      ↑         ↓          ↑
  dm-STR   ↑         ↑          ↑

*Data from: Ceglia et al., [@B61]; Calcagno et al., [@B49], [@B48]; Carli et al., [@B53],[@B54]; Agnoli et al., [@B11]*.

↑, *increase;* ↓, *decrease*.

The activation of glutamate neurotransmission in the mPFC and increased firing activity of pyramidal-projecting neurons may drive the increase in endogenous glutamate release in the dm-STR, which in turn may increase GABA and DA release. The NMDA/GABA interaction, regulate DA levels in the PFC and striatum (Balla et al., [@B27]). Reducing GABA transmission in the mPFC with GABA~A~ receptor antagonist bicuculline or infusion of glutamate increases DA release in the dorsal-STR and these effects are abolished by intracortical infusion of dizocilpine or the GABA~A~ agonist muscimol (Matsumoto et al., [@B163]). It is conceivable that glutamate by activating NMDA receptors on striatal medium spiny GABA neurons or interneurons facilitates GABA release (Morari et al., [@B173], [@B174], [@B172]; Young and Bradford, [@B247]).

Systemic administration of NMDA receptor antagonists such as ketamine and PCP had no significant effect on extracellular glutamate in the striatum (Lillrank et al., [@B150]; Moghaddam et al., [@B170]), and caused no changes or increased basal but inhibited K^+^ evoked GABA release (Lillrank et al., [@B150]; Hondo et al., [@B129]). These findings suggest that different NMDA receptor antagonists may have different effects on extracellular glutamate and GABA depending on the route of administration and brain region considered.

These findings in rats are paralleled by data from functional magnetic resonance imaging (fMRI) in human subjects showing that NMDA receptor antagonist such as ketamine at doses that cause specific behavioral impairment in the executive component of a working memory task (Honey et al., [@B130]), increases BOLD response in a brain system comprising frontal cortex, parietal cortex, putamen, and caudate nucleus (Honey et al., [@B131]) and increases glutamine, a putative marker of glutamate release (Rowland et al., [@B213]). Some more recent studies assessing PFC activation and global connectivity within a working memory network during rest or during task performance have reported an increased or decreased ketamine-associated activation, respectively (Driesen et al., [@B89],[@B90]).

Serotonin/NMDA receptors interaction and attention performance
==============================================================

Cortical 5-HT receptors
-----------------------

The functions of 5-HT are afforded by the concerted actions of multiple 5-HT receptor subtypes and as shown repeatedly 5-HT through its receptor subtypes exert diverse, often antagonistic actions on the same behavioral response. Several lesion and pharmacological studies have attempted to define the role of 5-HT and its various receptors in different aspects of 5-CSRT task (for a review of these studies see Robbins, [@B208]).

The mPFC receives extensive 5-HT innervation from the dorsal (DR) and median (MR) raphè nuclei and contains several 5-HT receptors, with particular abundance of 5HT~1A~ and 5-HT~2A~ and 5-HT~2C~ subtypes (Azmitia and Segal, [@B25]; Steinbusch, [@B229]; Blue et al., [@B39]; Jakab and Goldman-Rakic, [@B136], [@B137]; Barnes and Sharp, [@B28]; Clemett et al., [@B71]; Pandey et al., [@B184]). In the PFC the 5-HT1A and 5-HT2A receptors are expressed throughout cortical regions with a greater proportion of expression on pyramidal rather than GABA interneurons (Santana et al., [@B217]). The 5-HT~2C~ receptors are mainly expressed on pyramidal neurons (Clemett et al., [@B71]; Puig et al., [@B202]) and not in fast-spiking interneurons (Puig et al., [@B202]) but another immunohistochemical study using a different antibody shows more than 50% of the 5-HT~2C~ receptors on GABA neurons (Liu et al., [@B151]). These 5-HT receptors have been extensively characterized in terms of their localization to pyramidal and GABA interneurons as well as biochemically and electrophysiologically and a detailed review of their impact on cortical neuron activity can be found in Celada et al. ([@B62]).

Stimulation of 5-HT~1A~ receptors by 8-OH-DPAT inhibits NMDA-mediated synaptic excitation in the rat visual cortex (Edagawa et al., [@B93]) and suppresses glutamate signaling in the PFC by reducing NMDA and AMPA receptor currents (Cai et al., [@B47]). *In vitro* studies show that activation of 5-HT~1A~ receptor reduces NMDA-evoked glutamate release elevation while their blockade has opposite effects (Matsuyama et al., [@B164]; Maura and Raiteri, [@B165]). In *in vivo* studies PFC application of 8-OH-DPAT does not affect NMDA-evoked glutamate release, while the 5-HT~1A~ receptor antagonist WAY100135 enhance basal and NMDA-evoked glutamate release in the striatum (Dijk et al., [@B87]). Additionally, the 5-HT~1A~ partial agonists and full antagonists attenuate working memory deficits as well as psychotomimetic effects induced by NMDA antagonists (Harder and Ridley, [@B121]; Wedzony et al., [@B240]). Stimulation of 5-HT~1A~ somatodendritic autoreceptors in the DR or blockade of post-synaptic 5-HT~1A~ receptors in the hippocampus remediate the spatial learning deficit induced by blockade of NMDA receptors (Carli et al., [@B52]).

Activation of 5-HT~2A~/~2C~ receptors by DOI enhances the firing of pyramidal neurons (Puig et al., [@B201]) and 5-HT release dependent on activation of AMPA receptors (Martin-Ruiz et al., [@B162]) and increases glutamate levels in the somatosensory cortex (Scruggs et al., [@B220], [@B221]). Activation of 5-HT~2A~/~2C~ receptors in the PFC modulates GABAA receptor currents (Feng et al., [@B98]) and increases GABA release (Abi-Saab et al., [@B3]). Blockade of 5-HT~2A~ receptors reduces NMDA antagonists-induced *fos* expression (Habara et al., [@B117]), motor hyperactivity (Gleason and Shannon, [@B107]; Martin et al., [@B161], [@B160]; Swanson and Schoepp, [@B231]), forced swimming immobility (Corbett et al., [@B76]) and pre-pulse inhibition (PPI) (Varty et al., [@B236]). Blockade of 5-HT~2C~ receptors enhances NMDA antagonists-induced motor hyperactivity and DA release (Hutson et al., [@B133]).

Performance in the 5-CSRT task
==============================

The effects of 5-HT~1A~, 5-HT~2A~, and 5-HT~2C~ receptor agents after systemic or intra-mPFC injections on attention and executive deficits induced by R-CPP (50 ng/sise) injected in the mPFC are summarized in Table [3](#T3){ref-type="table"}.

###### 

**Summary of the effects of intra-mPFC R-CPP in combinations with 5-HT~1A~, 5-HT~2A~, and 5-HT~2C~ agents, an mGlu~2/3~ agonist and various antipsychotics on attention and executive control and glutamate (GLU) and serotonin (5-HT) release in the mPFC**.

                                                                                                                     **Attention**   **Impulsivity**   **Compulsivity**   **GLU**   **5-HT**
  ------------------------------------------------------------------------------------------------------------------ --------------- ----------------- ------------------ --------- ----------
  R-CPP[^a^](#TN4){ref-type="table-fn"}^,^[^b^](#TN5){ref-type="table-fn"}                                           ↓               ↑                 ↑                  ↑         ↑
  **SEROTONIN AGENTS**                                                                                                                                                              
  \+ 8-OH-DPAT[^c^](#TN6){ref-type="table-fn"}^,^[^d^](#TN7){ref-type="table-fn"}                                    0               ↑                 0                  0         0
  \+ M100907[^a^](#TN4){ref-type="table-fn"}^,^[^c^](#TN6){ref-type="table-fn"}^,^[^d^](#TN7){ref-type="table-fn"}   0               0                 ↑                  0         0
  \+ Ro60-0175[^e^](#TN8){ref-type="table-fn"}                                                                       0               0                 ↑                  0         0
  **mGlu~2/3~ AGENTS**                                                                                                                                                              
  \+ LY379268[^f^](#TN9){ref-type="table-fn"}                                                                        0               0                 ↑                  0         nd
  **ANTIPSYCHOTICS**                                                                                                                                                                
  \+ haloperidol[^g^](#TN10){ref-type="table-fn"}^,^[^h^](#TN11){ref-type="table-fn"}                                ↓               0                 0                  ↑         0
  \+ aripiprazole[^h^](#TN11){ref-type="table-fn"}                                                                   0               ↑                 0                  0         0
  \+ olanzapine[^h^](#TN11){ref-type="table-fn"}                                                                     0               0                 ↑                  0         0
  \+ clozapine[^i^](#TN12){ref-type="table-fn"}                                                                      0               0                 ↑                  0         0
  \+ sertindole[^i^](#TN12){ref-type="table-fn"} (0.32 mg/kg)                                                        0               ↑                 ↑                  0         0
  \+ sertindole[^i^](#TN12){ref-type="table-fn"} (2.5 mg/kg)                                                         ↓               ↑                 ↑                  ↑         ↑

Data from:

*Mirjana et al., [@B167]*,

*Ceglia et al., [@B61]*,

*Carli et al., [@B51]*,

*Calcagno et al., [@B49]*,

*Calcagno et al., [@B48]*,

*Pozzi et al., [@B250]*,

*Baviera et al., [@B32]*,

*Carli et al., [@B54]*,

*Carli et al., [@B53]*.

↓, *decrease;* ↑, *increase; 0, reversal of R-CPP-induced effect*.

Accuracy
--------

The behavioral manifestation of the functional interaction between 5-HT~1A~ and 5-HT~2A~ and 5-HT~2C~ with NMDA receptors in the mPFC is the demonstration that selective agonist at 5-HT~1A~ receptor 8-OH-DPAT and antagonist at 5-HT~2A~ receptor M100907 as well as 5-HT~2C~ receptor agonist Ro60-0175 recovered attentional performance deficit due to blockade of NMDA receptor in the mPFC, albeit in a distinct manner (Mirjana et al., [@B167]; Carli et al., [@B51]; Calcagno et al., [@B48]). Microinjections of 8-OH-DPAT or M100907 in the mPFC prevent accuracy deficit (Carli et al., [@B51]). Clearly, the functional opposition between the two 5-HT receptor subtypes on accuracy suggest that the improvement produced by M100907 and 8-OH-DPAT might reside in their opposite activity on common cellular substrates (Araneda and Andrade, [@B17]; Ashby et al., [@B22]; Celada et al., [@B62]). The 5-HT~1A~ but not 5-HT~2A~ or 5-HT~2C~ receptors appear to be involved in decision processes in this task as 8-OH-DPAT but not M100907 or Ro60-0175 reduced correct response latency and omissions (Mirjana et al., [@B167]; Carli et al., [@B51]; Calcagno et al., [@B48]). DA system and in particular D~1~ receptor in the PFC and in the dm-STR have been shown to impact decision processes in this task (Granon et al., [@B112]; Robbins, [@B208]); (see Table 2 in Agnoli et al., [@B11]). The fact that 8-OH-DPAT infused in the mPFC increases DA efflux in this cortical region (Sakaue et al., [@B215]) may at least in part explain its effects on speed and omissions.

Injections of 8-OH-DPAT and M100907 in the mPFC in control rats had no effect on accuracy, which is in contrast to what reported by other studies. The effects of 5-HT~1A~ agonists on accuracy in normal rats performing the task under basal conditions depend on whether the 5-HT~1A~ somatodendritic autoreceptors or post-synaptic receptors are activated. Systemic 8-OH-DPAT impaired accuracy and this effect was abolished by 5,7-dihydroxytryptamine lesion or blockade of 5-HT receptors in the DR by a selective 5-HT~1A~ antagonist WAY100635 (Carli and Samanin, [@B58]). In contrast, Winstanley et al. ([@B242]) reports a facilitation of accuracy after systemic or intra-cortical injections of 8-OH-DPAT. The role of 5-HT~2A~ receptors in accuracy is much less clear as systemic M100907 had no effect (Winstanley et al., [@B243]) and intra-mPFC injection facilitated accuracy at long but not short stimulus duration (Winstanley et al., [@B242]). The 5-HT~2C~ receptor do not appear to control accuracy in normal rats as no effect on accuracy has been reported after 5-HT~2C~ receptor agonists or antagonists (Higgins et al., [@B125]; Winstanley et al., [@B243]; Fletcher et al., [@B100], [@B99]).

Impulsivity and compulsivity
----------------------------

In contrast to the effects of 5-HT~2A~ receptor antagonist, which reduced premature responses but not perseverative over-responding either after systemic or intra-cortical injection (Mirjana et al., [@B167]; Carli et al., [@B51]), activation of 5-HT~1A~ receptors in the mPFC had no effect on premature but decreased perseverative over-responding (see Table [3](#T3){ref-type="table"}). 5-HT acting on 5-HT~2A~ receptors segregated to apical dendrites of pyramidal neurons (Jakab and Goldman-Rakic, [@B136]) and to GABA interneurons specialized in the perisomatic inhibition of pyramidal cells (Jakab and Goldman-Rakic, [@B137]) can affect excitatory input (Aghajanian and Marek, [@B5]) and by acting on 5-HT~1A~ receptors in the axon hilloc (DeFelipe et al., [@B84]; Czyrak et al., [@B77]) can suppress the generation of action potential along the axon and influence the activity in subcortical projection areas. Thus, by finely tuning the complex activity of glutamatergic pyramidal neurons, 5-HT may differently influence distinct aspects of executive control. These results clearly demonstrate the selectivity of executive control processes and indicate that impulsivity and compulsivity may be dissociated by 5-HT~1A~ and 5-HT~2A~ receptor mechanisms in the mPFC.

The effects of systemic M100907 and Ro60-0175 on R-CPP-induced impulsivity (Mirjana et al., [@B167]; Calcagno et al., [@B48]) are consistent with studies showing similar effects of these compounds on impulsivity but not compulsivity induced by systemic injections of NMDA antagonists dizocilpine and Ro63-1908 (Higgins et al., [@B126]; Fletcher et al., [@B99]). In contrast the 5-HT~2C~ antagonist SB242084 increased premature responses already in control rats and tended to enhance dozocilpine-induced impulsivity (Higgins et al., [@B126]).

Previous studies have suggested that enhanced impulsivity in the 5-CSRT task is associated with increased 5-HT turn-over (Puumala and Sirvio, [@B203]) and release in the PFC (Dalley et al., [@B80]) and activation of 5-HT~2A~/~2C~ receptors by DOI (Koskinen et al., [@B142]). However, global forebrain 5-HT depletion consistently results in enhanced impulsivity (Soubrié, [@B228]; Harrison et al., [@B122]; Carli and Samanin, [@B58]; Mobini et al., [@B169]). This apparent discrepancy may be resolved by 5-HT exerting inhibitory activity on impulsivity through 5-HT~2C~ but not 5-HT~2A~ receptors since decreasing their activity leads to impulsivity (Higgins et al., [@B126]; Winstanley et al., [@B243]; Fletcher et al., [@B100]). This suggestion is further supported by findings that activation of 5-HT~2C~ receptors decreases while their suppression increases premature responding in the 5-CSRT task under various conditions such as when the waiting period is increased (Carli, [@B50]; Fletcher et al., [@B100]) or premature responding is enhanced by NMDA receptor antagonists (Higgins et al., [@B126]; Calcagno et al., [@B48]).

Like systemic NMDA receptor antagonists, intra-mPFC infusion of R-CPP enhances DA release in the mPFC (Table [2](#T2){ref-type="table"}) (Moghaddam et al., [@B170]; Del Arco and Mora, [@B85]; Feenstra et al., [@B97]). Increasing DA transmission by d-amphetamine increases perseverative responses in the 5-CSRT task (Baunez and Robbins, [@B31]). Although microdialysis studies show that 8-OH-DPAT increases DA release in the mPFC (Arborelius et al., [@B18]; Sakaue et al., [@B215]) it actually reduces the rise in cortical DA release induced by d-amphetamine, stress and isolation rearing (Rasmusson et al., [@B205]; Kuroki et al., [@B143]; Ago et al., [@B12]) and attenuate d-amphetamine-induced motor activation (Przegalinski and Filip, [@B200]). The D~2~ receptor antagonist haloperidol also decreases R-CPP-induced perseverative responding (Baviera et al., [@B32]) (Table [3](#T3){ref-type="table"}). It is plausible that 8-OH-DPAT could decrease perseverative responding through its action on DA mechanisms. However, the effects of 8-OH-DPAT were due to activation of 5-HT~1A~ receptors in the mPFC as a selective 5-HT~1A~ antagonist WAY100635 completely blocked the effects of 8-OH-DPAT on accuracy deficit and perseverative responding (Carli et al., [@B51]).

Comparison with mGlu~2/3~ receptors
-----------------------------------

It is worth noting that the effects of M100907 on R-CPP-induced impairments in 5-CSRT task performance and the increase in glutamate release in the mPFC (see Table [3](#T3){ref-type="table"}) are mimicked by mGlu~2/3~ receptor agonist LY379268 (Pozzi et al., [@B250]). 5-HT-evoked excitatory post-synaptic currents are similarly inhibited by 5-HT~2A~ antagonist M100907 and by mGlu~2/3~ receptor agonists (1S,3S)-ACPD and LY354740 and enhanced by the mGlu~2/3~ antagonist LY341495 (Aghajanian and Marek, [@B6], [@B7]; Marek et al., [@B159]). Activation of 5-HT~2A~ receptors by DOI or LSD increases excitatory post-synaptic currents and potentials, glutamate release, c-fos in PFC, and induces head-twitch response (Aghajanian and Marek, [@B7]; Gewirtz and Marek, [@B105]; Klodzinska et al., [@B141]; Zhai et al., [@B249]; Gonzalez-Maeso et al., [@B110]). All these effects are blocked by 5-HT~2A~ antagonists or by mGlu~2/3~ agonists. This functional analogy may be based in part on anatomical overlap of mGlu~2~ particularly in apical dendrites of lamina V with the riches distribution of 5-HT~2A~ receptors (Blue et al., [@B39]; Aghajanian and Marek, [@B6]; Marek et al., [@B159], [@B158]) but may also derive from the mGlu~2~ receptor forming a complex through the specific transmembrane helix with 5-HT~2A~ receptor (Gonzalez-Maeso et al., [@B110]).

Dorsal striatal 5-HT receptors
------------------------------

The 5-HT afferents arising mainly in the DR nucleus (Steinbusch, [@B229]) innervate all components of the basal ganglia circuitry (Lavoie and Parent, [@B144]). The fact that 5-HT modulates not only DA but also GABA and glutamate neurotransmission in the dorsal striatum and output regions of the basal ganglia (Nicholson and Brotchie, [@B181]) suggest a 5-HTergic regulation of action selection and motor control (Di Matteo et al., [@B88]) but little is known about their contribution to cognitive function.

Among the various 5-HT receptor subtypes present within dorsal striatum the 5-HT~2A~ and 5-HT~2C~ receptors are particularly abundant (Barnes and Sharp, [@B28]). They are equally distributed on medium spiny neurons (MSN) forming the direct striatonigral and the indirect striatopallidal output projections but also on GABA and cholinergic (ACh) interneurons (Ward and Dorsa, [@B239]; Eberle-Wang et al., [@B92]). These 5-HT~2~ receptor subtypes play a prominent role in the modulation of striatal DA function (Abdallah et al., [@B1]; Navailles and De Deurwaerdere, [@B179]) and excite striatal ACh and fast spiking GABA interneurons (Blomeley and Bracci, [@B37], [@B38]). The 5-HT~2~ receptor antagonists administered within the striatum block DA-mediated oral activity (Plech et al., [@B196]), synergize D~1~-induced locomotor activity (Bishop and Walker, [@B36]) and cause retrograde amnesia in rats (Prado-Alcala et al., [@B198],[@B199]). Loss of 5-HT~2C~ receptors enhances behavioral sensitivity to D~1~ receptor activation (Abdallah et al., [@B1]).

Performance in the 5-CSRT task
==============================

The effects of 5-HT~2A~ and 5-HT~2C~ receptor agents injected in the dm-STR on attention and executive deficit induced by R-CPP (50 ng/side) injections in the mPFC are summarized in Table [4](#T4){ref-type="table"}.

###### 

**The effects of serotonin and dopamine receptors agents injected in the dm-STR on attention and executive deficits induced by R-CPP injections in the mPFC**.

                                                 **Accuracy**   **Impulsivity**   **Compulsivity**
  ---------------------------------------------- -------------- ----------------- ------------------
  R-CPP                                          ↓              ↑                 ↑
  **+ SEROTONIN AGENTS**                                                          
  M100907[^a^](#TN13){ref-type="table-fn"}       0              0                 0
  Ro60-0175[^a^](#TN13){ref-type="table-fn"}     0              0                 0
  **+ DOPAMINE AGENTS**                                                           
  SCH23390[^b^](#TN14){ref-type="table-fn"}      0              0                 ↑
  haloperidol[^b^](#TN14){ref-type="table-fn"}   ↓              0                 0

Data from

*Agnoli and Carli, [@B9]*,

*Agnoli et al., [@B11]*.

*↓, decrease; ↑, increase; 0, reversal of R-CPP-induced effect*.

Accuracy
--------

Activation of 5-HT~2C~ or blockade of 5-HT~2A~ receptors in the dm-STR reduce accuracy deficit induced by R-CPP. These data concur with the above discussed data showing opposing roles of these receptors on the neurochemical processes that support the 5-CSRT task performance deficits induced by NMDA receptor antagonists. However, cortical 5-HT~2A~ receptors exert a much more effective control over attention as much higher dose of M100907 had to be administered in the dm-STR than in the mPFC to achieve an effect on accuracy. The PFC shows much higher levels of 5-HT~2A~ hybridization signals than the dorsal striatum (Pompeiano et al., [@B197]) and there is a substantial and reciprocal control of the activity of DR cortical 5-HT neurotransmission by PFC (Hajos et al., [@B119], [@B118]; Celada et al., [@B63]). This control has an important functional role; for example 5-HT depletion abolishes the facilitatory effects of M100907 on accuracy and its ability to prevent R-CPP-induced glutamate release in the mPFC (Winstanley et al., [@B243]; Calcagno et al., [@B48]) but also in stress-induced activation of DR (Amat et al., [@B13]). The DR from which originates the 5-HT projection to the dorsal striatum does not receive reciprocal innervation from the striatum indicating no direct modulation by striatal feedback (Casanovas et al., [@B59]).

Impulsivity and compulsivity
----------------------------

In contrast to the lack of effect of systemic or intracortical M100907 and Ro-60-0175 on perseverative responding, M100907 and Ro60-0175 administered locally in the dm-STR reduced perseverative responding caused by R-CPP. As systemic injections of these 5-HT~2~ agents had no effect on R-CPP-induced perseverative over-responding it is conceivable that the reduction of perseverative responding in one brain area such as dm-STR, is compensated by opposite effects in other brain regions. In fact, M100907 injected in the ventral tegmental area (VTA) further enhanced perseverative responding caused by blockade of NMDA receptors in the mPFC (Agnoli and Carli, [@B10]). These findings are in keeping with evidence that different 5-HT receptor subtypes have distinct roles in the modulation of perseverative responses, depending on the type of cognitive process engaged by the task and brain area. For example, 5-HT in the PFC is not essential for higher-order shifting of attentional set while it is critical for the flexible responding in a reversal learning task (Clarke et al., [@B70]). The 5-HT~2A~ and 5-HT~2C~ receptors exert functionally opposing action on perseverative responding in a spatial-reversal task (Boulougouris et al., [@B42]) while suppression of 5-HT~2C~ receptors in the orbitofrontal cortex but not in PFC decreases perseverative errors in a similar reversal-learning task (Boulougouris and Robbins, [@B43]).

It is worth noting that the ability of intra-STR M100907 and Ro60-0175 to remove impulsivity and compulsivity induced by blockade of mPFC NMDA receptors is remarkably similar to what found after systemic or intra dm-STR injections of a D~2~ receptor antagonist haloperidol (Baviera et al., [@B32]; Agnoli et al., [@B11]). It should be noted that blockade of NMDA receptors in the mPFC increases glutamate, GABA, and DA release in the dm-STR (see Table [2](#T2){ref-type="table"}). As pointed above substantial neurochemical and behavioral evidence support the suggestion that 5-HT can influence DA\'s effects in the striatum, which may be of relevance for the observed analogy in the behavioral effects 5-HT~2A~ and 5-HT~2C~ receptor agents and D~2~ receptor antagonists. However, as M100907 and Ro60-0175 but not haloperidol had additional effects on accuracy deficit other likely non-D~2~, mechanisms in the dm-STR may also contribute. Local infusion of M100907 has been shown to decrease basal and MPTP-stimulated glutamate levels in the dorsal striatum and ameliorate behavioral impairment of MPTP-treated mice (Ansah et al., [@B16]).

Activation of 5-HT receptors in the striatum elicits predominantly inhibitory responses in the medium spiny (MS) projection neurons (el Mansari et al., [@B95]; el Mansari and Blier, [@B94]). 5-HT though 5-HT~2C~ excites striatal ACh interneurons, which in turn inhibit the glutamatergic input to MS projection neurons (Pakhotin and Bracci, [@B183]). Notably changes in firing activity of ACh interneurons encode behaviorally relevant information (Morris et al., [@B175]; Yamada et al., [@B244]). Activation of 5-HT~2C~ receptors strongly increases the firing of GABAergic interneurons in the striatum, which potently inhibit striatal output (Blomeley and Bracci, [@B38]). Thus, 5-HT~2~ receptor subtypes through a likely action on glutamate, ACh and GABA mechanisms in the dm-STR may integrate the glutamate cortico-striatal inputs critical for the different aspects of performance in the 5-CSRT task.

Dopamine/NMDA receptors interaction and attention performance
=============================================================

Dorsal striatal D~1~- and D~2~-like receptors
---------------------------------------------

DA receptors are broadly expressed in the brain with a distribution largely matching the density of innervating DA fibers (Bentivoglio and Morelli, [@B33]). Among the DA receptors the D~1~ and D~2~ receptor subtypes display the widespread distribution and the highest expression levels. They are most prominent in the dorsal and ventral striatum, olfactory tubercle, and cortex (Bentivoglio and Morelli, [@B33]).

In the striatum the D~1~ and D~2~ receptors are segregated to the two MSN output populations of neurons forming direct striato-nigral and indirect striato-pallidal patways, respectively. However, both D~1~ and D~2~ receptors are expressed in a subset of MSN neurons in the striatum. Whether cooperative effects of D~1~ and D~2~ receptors observed in some studies (Perreault et al., [@B192]) arise from complex network interactions or from their co-localization in some MSN neurons is unclear. Striatal interneurons although proportionally small (5--10% of total neuronal population) exert powerful influence on striatal output. Five distinct GABA subtypes (distinguished by different neuropeptide expression, synthetic enzymes and calcium binding proteins) and one type of ACh interneurons are present. D~2~ and D~1~-like (D~5~) receptors are expressed in ACh interneurons while some GABA interneurons express D~1~-like (D~5~) receptors. D~2~ receptor is expressed also on presynaptic DA terminals of DA afferents as well as in glutamatergic cortical and thalamic afferents. D~1~ receptors have also been found in a small number of presynaptic glutamatergic terminals (Bentivoglio and Morelli, [@B33]).

Numerous studies have demonstrated that DA through pre- and post-synaptic D~1~ and D~2~ receptors modulate the probability of release at glutamate, GABA and ACh terminals, ionotropic glutamate, and GABA receptor function and trafficking, post-synaptic excitability and synaptic integration in striatal projecting neurons and interneurons as well as in cortical pyramidal cells and interneurons. DA bi-directionally modulates synaptic NMDA receptors through its D~1~- and D~2~-like receptors, but the responses of individual neurons across brain areas and the intracellular pathways recruited vary greatly. These studies (for a comprehensive review see Surmeier et al., [@B230]; Tritsch and Sabatini, [@B234]) reveal the complex nature and consequences of this modulation on neural networks implicated in motor, cognitive, and motivational processes (Di Chiara, [@B86]; Dunnett, [@B91]; Robbins, [@B209]; Berridge, [@B34]; Salamone and Correa, [@B216]).

Performance in the 5-CSRT task
==============================

The effects of D~1~- and D~2~-like receptor antagonists SCH23390 and haloperidol injected in the dm-STR on accuracy and executive deficits induced by R-CPP injections in the mPFC are summarized in Table [4](#T4){ref-type="table"}.

Accuracy
--------

In rats in which accuracy was impaired by intra-mPFC injections of R-CPP (50 ng/side) suppression of D~1~-like receptor activity in the dm-STR by an antagonist such as SCH23390 prevented accuracy deficit. It could be argued that in rats performing the 5-CSRT task at a very high level of efficiency (i.e., high accuracy) the activity at dorsal striatal D~1~-like receptors may be already at a maximum and any further activation such as that operated by intra-mPFC injections of R-CPP (Table [2](#T2){ref-type="table"}) may have detrimental effects. On the other hand, concomitant infusion of SCH23390 and R-CPP in the dm-STR at individually ineffective doses had detrimental effects on accuracy (Agnoli and Carli, [@B9]). Thus, suppression of D~1~ receptor function in the dm-STR has positive or detrimental effects on accuracy depending on whether cortico-striatal neurotransmission is increased or decreased. Interestingly, another study also reported that systemic SCH23390 tend to improve accuracy of rats with excitotoxic lesion to mPFC (Passetti et al., [@B187]).

These findings stand rather alone as in the majority of published studies the effects of D~1~-like agents was examined in normal rats performing the task under baseline conditions. The picture that emerges is that detrimental effects of SCH23390 on accuracy of rats performing the task under basal conditions depend on dose, brain area, and baseline level of accuracy (Granon et al., [@B112]; Pezze et al., [@B194]). In rats performing the task at relatively high level of accuracy (between 80 and 90%) SCH23390 injected in the mPFC or NAC impairs accuracy (Granon et al., [@B112]; Pezze et al., [@B194]) while the same dose (100 ng) injected in the dm-STR had no effect (Agnoli and Carli, [@B9]). Similarly the effect of SKF38393 a D~1~-like receptor agonist on accuracy is also baseline dependent; injected in the dm-STR or given systemically impairs accuracy of rats performing at high levels of efficiency (about 90%correct) whereas injected in the mPFC boosts accuracy but only in poorly performing rats (about 70% correct) (Granon et al., [@B112]). SKF38393 injected in the NAC boost accuracy of rats performing at less than 80% correct but only at the lowest dose tested (100 ng) while the same dose injected in the dorsolateral striatum had no effect. These discrepancies in the effects of D~1~ receptor agents on accuracy are far from surprising as it has been repeatedly shown that the effects of D~1~ receptor manipulation on task performance depend on the optimal levels of DA for the particular task (Sawaguchi and Goldman-Rakic, [@B219]; Arnsten, [@B19]; Zahrt et al., [@B248]; Granon et al., [@B112]; Pezze et al., [@B193]; Chudasama and Robbins, [@B69]; Robbins, [@B209]). This is reminiscent of the Yerkes-Dodson principle based on the inverted U-shaped function relating levels of arousal/activation with efficiency of behavioral performance (Robbins, [@B209]) but also to the inverted U-shaped function relating D~1~ receptor activation and NMDA-EPSC changes (Seamans and Yang, [@B222]; Trantham-Davidson et al., [@B233]; Tritsch and Sabatini, [@B234]). As for PFC an inverted U-shaped function may relate D~1~ receptor stimulation in the dm-STR to the efficiency of attentional functioning.

Contrasting with the findings above, suppression of D~2~-like receptor activity in the dm-STR by local injections of haloperidol has no effect in control rats and is unable to recover accuracy deficit caused by blockade of NMDA receptors in the mPFC (Agnoli et al., [@B11]). Similar lack of effects on R-CPP-induced accuracy deficit is observed after systemic haloperidol (Baviera et al., [@B32]). However, the doses used in these studies were effective in reversing other R-CPP-induced effects (see below). That D~2~-like receptors in the dorsal striatum are unlikely to be involved in governing accuracy is supported by data showing that their activation by quinpirole an agonist at these receptors has no effect either injected in the dorsomedial or dorsolateral striatum (Pezze et al., [@B194]; Agnoli et al., [@B11]). Doses of haloperidol and quinpirole higher than those reported in the studies by Baviera et al. ([@B32]) and Agnoli et al. ([@B11]) cannot be tested in the 5-CSRT task as rats stop responding or make mostly omissions.

Systemic haloperidol do not allows for the precise definition of the locus of D~2~ receptor suppression. However, after systemic administration haloperidol binds comparable proportion of D~2~ receptors in the striatum (caudate-putamen) and in the frontal cortex (Mukherjee et al., [@B177]) and the protein structure of the D~2~ receptors throughout the brain are similar and so is their *in vitro* affinity (Seeman and Ulpian, [@B223]). It is worth noting that a chemically different D~2~-like receptor antagonist such as l-sulpiride injected in the mPFC had no effect on accuracy (Granon et al., [@B112]). Although these findings may suggest that cortical D~2~-like receptors do not contribute to accuracy further studies are necessary to better delineate the role of PFC D~2~ receptors in attention. However, l-sulpiride given systemically or in the NAC impairs accuracy in control rats but prevents accuracy deficit in rats bearing excitotoxic lesions of the mPFC (Passetti et al., [@B187]; Pezze et al., [@B195]). L-sulpiride does not discriminate between D~2~ and D~3~ receptor subtypes (Missale et al., [@B168]). The D~3~ receptors are present at very low levels in the mPFC and dorsal striatum but are particularly abundant in the NAC and limbic regions (Sokoloff et al., [@B227]; Bentivoglio and Morelli, [@B33]) and hence it could not be excluded the possibility that D~3~ receptors in the NAC may account for the effect of l-sulpiride. However, as systemic or intra-NAC nafadotride, a preferential D~3~ (compared to D~2~) receptor antagonist (Sautel et al., [@B218]) has no effect on accuracy (Besson et al., [@B35]) the precise contribution of D~3~ receptors for the control of accuracy has yet to be fully disclosed.

Intra-dm-STR injections of haloperidol or SCH23390 did not reduce the R-CPP-induced increase in omissions and correct response latencies. It is unlikely that the increased proportion of omissions was due to a change in motivation as the latency to collect the food, which is a more direct measure of motivation was not affected. This increase in omissions may indicate an inability to maintain voluntary control over sustained performance due to motor hyperactivity. However, haloperidol and SCH23390 did not reduce R-CPP-induced motor hyperactivity (Agnoli, [@B8]). SKF38393 speeded correct responses and decreased omissions when injected in the dm-STR (see Table 2 in Agnoli et al., [@B11]) similarly to what reported after intra-mPFC injection of this compound while systemic SKF38393 decrease correct response latencies (Passetti et al., [@B186]). These finding are broadly consistent with a general performance scaling function of tonic DA activity (Cagniard et al., [@B46]) and with evidence from other reaction time tasks that striatal DA is implicated in decisional processes (Carli et al., [@B55], [@B56]; Robbins and Brown, [@B211]; Brown and Robbins, [@B44]).

Impulsivity and compulsivity
----------------------------

Dorsomedial striatal D~1~-like and D~2~-like receptors play an important role in the expression of impulsivity in the 5-CSRT task as both SCH23390 and haloperidol injected in the dm-STR dose-dependently reversed R-CPP-induced premature over-responding, a proxy of impulsivity. Blockade of these D~1~- and D~2~-like receptors in control conditions had no effect or decrease premature responses depending on the dose employed and the number of premature responses made by rats under the control condition (Agnoli and Carli, [@B9]; Agnoli et al., [@B11]) while their activation by SKF38393 and quinpirole, respectively increase premature responses (Agnoli et al., [@B11]). The finding that R-CPP-induced motor hyperactivity was not affected by SCH23390 and haloperidol (Agnoli, [@B8]) suggest that their ability to decrease R-CPP-induced impulsivity is not due to alteration in motor activity and helps dissociating impulsivity from changes in motor activity.

These findings question the prevailing hypothesis that impulsivity can be mostly attributed to the mesolimbic not the nigrostriatal DA system as d-amphetamine-induced impulsivity in the 5-CSRT task was abolished by ventral striatal but not dorsal striatal DA depletion (Cole and Robbins, [@B73]; Baunez and Robbins, [@B31]). In addition other studies had shown that D~1~- but not D~2~-like receptors in the NAC core contribute to impulsivity under basal conditions (Pezze et al., [@B194]) whereas D~2~-like receptors in the NAC appear to come into play only under perturbed conditions such as those induced by amphetamine or in rats made impulsive by excitotoxic lesion of the PFC (Cole and Robbins, [@B72]; Pattij et al., [@B188]; Pezze et al., [@B195]). In the case of high-impulsive rats D~2/3~ antagonist nafadotride alleviated or exacerbated impulsivity depending whether injected in the core or shell sub-region of the NAC, respectively (Besson et al., [@B35]). However, DA depletion in the dorsal striatum reversed impulsivity in the 5-CSRT task induced by lesions to the sub-thalamic nucleus (Baunez and Robbins, [@B31]) and D~2~ receptor availability in the dorsal striatum was associated with impulsiveness in methamphetamine-dependent subjects (Lee et al., [@B146]). Thus, the modulation of impulsivity by DA mechanisms in the dorsal striatum may be detected in particular conditions.

Haloperidol but not SCH23390 injected in the dm-STR reduce perseverative responding induced by blockade of NMDA in the mPFC. The effects of systemic and intra-dm-STR injected haloperidol are remarkably similar; both reduce perseverative and premature over-responding but not accuracy deficit (see, Tables [3](#T3){ref-type="table"}, [4](#T4){ref-type="table"}). These findings are in accord with a study showing that the "compulsive" stimulus bound perseveration of monkeys after frontal ablation is also alleviated by haloperidol (Ridley et al., [@B206]). However, other studies report that l-sulpiride either after systemic or intra-NAC injections had no effect in rats made compulsive by excitotoxic lesions of mPFC (Passetti et al., [@B187]; Pezze et al., [@B195]). The causes for the lack of effect of this D~2~/D~3~ antagonist are not clear and may depend on various factors such as whether emitting a perseverative responses leads to behavioral consequence or not, brain area or else; for example it has been repeatedly shown that similar pharmacological manipulations increase perseverative responding when these lead to time-out but not when they are without consequences (Harrison et al., [@B123]; Robbins, [@B208]; Mirjana et al., [@B167]; Winstanley et al., [@B243]; Murphy et al., [@B178]).

On the other hand, in normal rats performing the 5-CSRT task at baseline conditions activation of D~2~-like receptors in the dm-STR dose-dependently increase perseverative responding (Agnoli et al., [@B11]) similarly to what found after injections of similar doses of quinpirole in the NAC core but not after injections in the dorsolateral striatum (Pezze et al., [@B194]). That the perseverative responses in the 5-CSRT task may be modulated by nigrostriatal DA system is also suggested by paradoxical increase in these responses after dorsal striatal DA depletion (Baunez and Robbins, [@B31]) most likely due to the supersensivity of D~2~-receptors after 6-hydroxydopamine lesion (Ungerstedt, [@B235]). These findings are in agreement with other studies linking changes in D~2~ receptors function at various nodes of cortico-striatal circuit to flexible modification of behavior. Although it could not be assumed that perseverative errors in the 5-CSRT task and those made in other tasks such as for example in set-shifting, reversal learning or working memory represent the same psychological process, Floresco et al. ([@B102]) report increased number of perseverative errors after blockade of D~2~-like receptors in the mPFC in a maze based set-shifting task while Goto and Grace ([@B111]) report that PFC-dependent perseveration in a task requiring an egocentric response strategy depends on tonic DA release and D~2~-like receptor stimulation in the striatum. In addition, mice over-expressing D~2~ receptors in the striatum make more perseverative errors in a working memory task (Kellendonk et al., [@B140]). D~2~-receptor stimulation by quinpirole increases preseverative but not learning errors of rats performing a spatial reversal task (Boulougouris et al., [@B41]). The probability of perseverative responses of monkeys performing a three-choice reversal task is also related to D~2~-receptor availability in the dorsal striatum (Groman et al., [@B115]).

The lack of effects of D~1~-like receptor agents injected either systemically, in the mPFC, NAC or dm-STR on perseverative responding in the 5-CSRT task (Granon et al., [@B112]; Pezze et al., [@B194]; Agnoli and Carli, [@B9]; Barnes et al., [@B29]; Agnoli et al., [@B11]) contrast with evidence that D~1~-like receptors in the mPFC or NAC control perseverative type errors in set-shifting and working memory tasks (Zahrt et al., [@B248]; Ragozzino, [@B204]; Haluk and Floresco, [@B120]). Thus, both DA receptor subtypes act in a cooperative manner to control a component of set-shifting such as ability to disengage from the previously effective but now inappropriate strategy whereas in the 5-CSRT task they appear to control separate cognitive processes such as those engaged by accuracy of visual discrimination and perseverative responding. However, the perseverative over-responding in the 5-CSRT task may result from a deficit in the selection and integration of an adequate response in a long sequence, leading to reward rather than the inability to flexibly adapt to the shifts between rules, strategies and sets. The organization of complex sequences of actions and the ordering of movements within a sequence implicate dorsal striatum with its DA afferents (Graybiel, [@B113]; Hikosaka et al., [@B127]; Bailey and Mair, [@B26]; Jin and Costa, [@B138]; Jin et al., [@B139]). Notably, the D~1~-nigrostriatal and D~2~-striatopallidal basal ganglia pathways show concomitant activity during action selection and initiation but behave differently during the execution of action sequences (Jin et al., [@B139]).

Attention impairment and glutamate release in the mPFC
======================================================

One of the characteristics of the microdialysis technique is the possibility to deliver drugs through the probe while collecting neurotransmitters generated and secreted by cells. In our microdialysis studies unilateral perfusion of 100 μM R-CPP through the probe in the mPFC for 1 h evoked a marked and reliable increase of glutamate, 5-HT and DA and a reduction of GABA therein (Tables [2](#T2){ref-type="table"}, [3](#T3){ref-type="table"}). However, the non-competitive NMDA receptor antagonists dizocilpine and ketamine increased cortical 5-HT efflux after bilateral but not unilateral infusion into the mPFC (Lopez-Gil et al., [@B154]). Although different administration techniques were used in behavioral (intraparenchimal injection) and microdialysis (perfusion through the probe) studies, the total amount of R-CPP delivered were similar (see Discussion in Calcagno et al., [@B48]). In addition, extracellular glutamate increased to a similar extent after R-CPP perfusion through the probe or intraparenchimal injection of the drug (50 ng/side) at the same dose as used in behavioral studies (see Figure S2 in Calcagno et al., [@B48]). This strengthens the link between microdialysis and behavioral data.

The proposal that excessive prefronto-cortical glutamate release plays a key role in cognitive deficit stems from the study by Moghaddam and Adams ([@B171]) and is fuelled by a series of observation summarized in Table [3](#T3){ref-type="table"}. While impulsivity and compulsivity do not appear to be associated with glutamate release in the PFC, Table [3](#T3){ref-type="table"} illustrate a tight association between the ability of several compounds to prevent R-CPP-induced attention deficits in the 5-CSRT task and the stimulation of glutamate release in the rat mPFC. The first evidence for this association was obtained with the selective 5-HT~2A~ receptors antagonist M100907. It was found that the same systemic doses of M100907 preventing attention deficit in the 5-CSRTT abolished the R-CPP-induced glutamate relase in the mPFC (Ceglia et al., [@B61]). However, another study failed to observe such interaction (Adams and Moghaddam, [@B4]). The perfusion of M100907 through the probe mimicked the effect of systemic injection in suppressing R-CPP- (Ceglia et al., [@B61]) and dizocilpine-induced rise of extracellular glutamate in the mPFC (Lopez-Gil et al., [@B153]). These findings indicate that cortical 5-HT~2A~ receptors may play a major role and that the stimulation of glutamate release may play a role in the attentional performance deficits caused by NMDA receptor blockade. Cortical 5-HT~1A~ and 5-HT~2A~ receptors co-localize in most pyramidal neurons of the mPFC (Santana et al., [@B217]) and exert opposite effect on their excitability (Araneda and Andrade, [@B17]; Ashby et al., [@B22]), head-twitches behavior (Darmani et al., [@B81]) and cortical dopamine release induced by D~2~ receptor blockade (Ichikawa et al., [@B134]). On this basis, it is expected that 5-HT~1A~ receptor stimulation ameliorate attention deficit induced by R-CPP (Carli et al., [@B51]) by a mechanism similar to that of M100907. This was confirmed showing that intracortically perfused 8-OH-DPAT, a relatively selective 5-HT~1A~ receptors agonist, shared with M100907 the ability to prevent R-CPP-induced glutamate release in the mPFC (Calcagno et al., [@B49]). WAY100635 antagonized the effect of 8-OH-DPAT on glutamate release suggesting a selective involvement of 5-HT~1A~ receptors (Calcagno et al., [@B49]). These data were recently confirmed showing that dizocilpine-induced release of glutamate and 5-HT in the mPFC were suppressed by Bay × 3702, a 5-HT~1A~ receptor agonist (Lopez-Gil et al., [@B152]) and strengthen the suggestion that excessive glutamate in the mPFC is deleterious for attentional performance. Further support comes from studies showing that the 5-HT~2C~ receptor agonist Ro60-0175 mimicked M100907 in suppressing R-CPP-evoked glutamate release while the 5-HT~2C~ receptor antagonist SB242084 prevented the effect of M100907 on glutamate (Calcagno et al., [@B48]). This is not surprising in view of the well-recognized functional opposition between 5-HT~2A~ and 5-HT~2C~ receptors (Millan et al., [@B166]; Gobert and Millan, [@B108]) and suggests that 5-HT~2C~ receptors play a major role in controlling the effect of R-CPP on cortical glutamate release. Interestingly, R-CPP-induced rise of extracellular glutamate and 5-HT in the rat mPFC was prevented by M100907 and 5-HT depletion abolished these effects (Calcagno et al., [@B48]). Likewise, endogenous 5-HT is necessary for M100907 to inhibit motor activity induced by dizocilpine in mice (Martin et al., [@B160]). Although the effect of R-CPP on 5-HT is not related to its ability to impair attention or executive control (see Table [3](#T3){ref-type="table"}), it could be argued that enhanced 5-HT tone on cortical 5-HT~1A~ may contribute to the ability of M100907 to counteract the effect of R-CPP on glutamate. However, failure of WAY100635 to prevent the effect of M100907 on R-CPP-induced glutamate release (Calcagno et al., [@B48]) rules this out. Thus, it is likely that M100907 suppresses glutamate release induced by R-CPP by enhancing the action of endogenous 5-HT on 5-HT~2C~ receptors. Taken together, these findings suggest that an imbalance in the control exerted by endogenous 5-HT on different receptor subtypes, rather than an action at a single receptor, determines the effect of NMDA antagonists on glutamate release and behavior.

The role of glutamate release in attention performance is further supported by data showing that the activation of pre-synaptic mGlu2/3 receptors, which suppress glutamate release, was sufficient to reduce R-CPP-induced accuracy deficits in the 5-CSRT task (Table [3](#T3){ref-type="table"}). Similarly, the stimulation of mGlu2/3 receptors prevented the working memory impairment induced by PCP in the T-maze (Moghaddam and Adams, [@B171]).

Antipsychotic drugs show a complex pharmacology involving actions at different neurotransmitter receptors including agonist, antagonist, or partial agonist interactions with 5-HT~1A~, 5-HT~2A~, 5-HT~2C~ receptors (Arnt and Skarsfeldt, [@B21]), which may influence the effects of NMDA receptor antagonists on attention and cortical glutamate. In the 5CSRT task clozapine, olanzapine and low doses of sertindole prevented R-CPP-induced impairment of correct responses and impulsivity but had no effects on compulsivity (Baviera et al., [@B32]; Carli et al., [@B53],[@B54]) resembling the effect of M100907. These antipsychotics block with high affinity 5-HT~2A~ receptors (Arnt and Skarsfeldt, [@B21]), which likely played a major role in their effects on attention. Aripiprazole effect in the 5CSRT task resembled that of 8-OH-DPAT (see Table [3](#T3){ref-type="table"}) suggesting an involvement of 5-HT~1A~ receptor stimulation (Carli et al., [@B54]). Regardless of their precise mechanism of action, we found that clozapine, olanzapine, sertindole (low doses), and aripiprazole, which share the ability to counteract attention deficit induced by R-CPP, consistently suppressed R-CPP evoked glutamate release in the mPFC while 0.1 mg/kg haloperidol, which occupies most brain D~2~ receptors (Mukherjee et al., [@B177]) and 2.5 mg/kg sertindole, did not reverse attention deficits and had no effect of glutamate release (Table [3](#T3){ref-type="table"}). In line with these findings, other studies showed that clozapine and olanzapine prevented dizocilpine-induced glutamate release (Lopez-Gil et al., [@B153]). Although 0.3 and higher doses of haloperidol reversed R-CPP and dizocilpine effects on glutamate (Lopez-Gil et al., [@B152]; Carli et al., [@B54]), at 0.3 mg/kg rats stop responding or make mostly omissions, so their effects in the 5-CSRT task could not be reliably assessed. It should be emphasized that the same doses of drugs were used in our behavioral and microdialysis studies. This contributes to support the proposal that excessive glutamate release in the mPFC is deleterious for attention.

Conclusions {#s2}
===========

In this review a special emphasis was given to distinct processes that govern the performance of rats in the 5-CSRT task. It is apparent that the input selection process of attention and executive control over impulsive and perseverative responding may be the results of integration of NMDA receptor function and the activity in 5-HT and DA receptor systems along the nodes of cortico-striatal circuitry.

Blockade of NMDA receptors in the mPFC induces a profound deficit in rat\'s performance in the 5-CSRT task characterized by impaired attention, increased impulsivity and perseverative responding and hyperactivation of cortico-striatal transmission. The reviewed studies show that these deficits are differentially responsive to pharmacological manipulations of 5-HT and DA receptor activity in the mPFC and dm-STR and that increased cortical glutamate release and cortico-striatal transmission is associated specifically with impaired attention but not with enhanced impulsivity and perseverative responding.

Direct comparison of the effects of various 5-HT~1A~, 5-HT~2A~, and 5-HT~2C~ agonists and antagonists most clearly implicate these 5-HT receptors in the mPFC in the preservation of input selection process of attention. Impulsivity in the 5-CSRT task, which has been definitely linked to changes in 5-HT function (Dalley and Roiser, [@B79]) is best controlled by suppression of 5-HT~2A~ or activation of 5-HT~2C~ receptors. In contrast, perseverative response deficit appear to be responsive to activation of 5-HT~1A~ receptor in the mPFC and the suppression of 5-HT~2A~ and activation of 5-HT~2C~ receptors in the dm-STR and VTA. In view of the well-recognized control of striatal and cortical DA function by 5-HT~1A~ and 5-HT~2~ receptors and the similar effects of a D~2~-like receptor antagonist such as haloperidol on perseverative response deficit, it is likely that this 5-HT receptors\' control of perseverative responding may be the result of a functional interaction with D~2~-like receptor mechanisms. Manipulation of 5-HT receptors in another task putatively employed to evaluate similar processes confirms that, depending on the cortical area, 5-HT~2A~ and 5-HT~2C~ receptors exert functionally opposing action on perseverative responding (Boulougouris et al., [@B42]; Boulougouris and Robbins, [@B43]). Together, these studies highlight the complexity but also specificity of influences that 5-HT exert on prefrontal control of attention and executive functions depending on the receptor subtype, brain areas and specific processes engaged by the task.

The studies reviewed here also show a clear-cut dissociation in the roles played by dm-STR D~1~-like and D~2~-like receptors in the control of accuracy and perseverative responding. There is a definite relation between D~1~ receptor and attention but this relationship is not linear as it can be influenced by many factors such as the levels of baseline performance and optimal levels of DA for the performance of a particular task (Robbins, [@B209]). While accuracy is not responsive to D~2~-like receptor activity, the suppression of D~1~ receptor activity may improve or impair accuracy depending on the activity in the cortico-striatal transmission. The sensitivity of input selection process of attention to D1-like receptor manipulation in the dm-STR is in marked contrast to the lack of effect on processes underlying a form of behavioral flexibility such as that indexed by perseverative responses. Although there appears to be some overlap between D~1~-like and D~2~-like receptors in the modulation of certain domains of behavioral flexibility such as that involved in the ability to flexibly adapt to shift between rules, strategies, and sets (Floresco and Jentsch, [@B101]) the studies reviewed here clearly show that a different form of behavioral flexibility, which may result from the inability to select and integrate an adequate response in a long sequence leading to reward, is under control of D~2~-like but not D~1~-like receptor activity in the dm-STR. The two dorsal striatal DA receptor subtypes appear to act in a cooperative manner to control a different component of executive control such as impulsivity.

The suggestion emerging from this review is that the differential modulation of attention and executive functions by the 5-HT and DA systems highlights a degree of specificity for these "nonspecific" neurochemical pathways. These systems integrate the information conveyed by cortical pyramidal neurons at the level of functional modules, which are engaged selectively to optimize the operations necessary for the attentional and executive control over performance. The PFC controls the activity in these neurochemical pathways that in-turn they themselves modulate suggesting that this reciprocal control is essential for cognition.

The impairment in the 5-CSRT task performance by NMDA receptor antagonist administration in the mPFC may represent a model of attentional and executive dysfunction useful to explore the role of brain circuits and neurotransmitter systems in the cognitive symptoms of neuropsychiatric disorders.
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